1-Methylimidazole

1-Methylimidazole

SCHEMBL6522952

Cn1ccnc1.O=C(Cc1ccccn1)OC(=O)Cc1ccccn1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
NFKB1 P19838 1/20 0.42
QPCT Q16769 1/20 0.42
HSD17B10 Q99714 1/20 0.42
QPCTL Q9NXS2 1/20 0.42
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
TBXAS1 P24557 3/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL3396777 0.85 ALDH1A1 (0.53) CYP1A2ALDH1A1TSHRRAB9ANPC1
SCHEMBL375765 0.83 RAB9A (0.53) CYP1A2ALDH1A1TSHRRAB9ANPC1
Acetic Acid SCHEMBL6285526 0.81 ALDH1A1 (0.53) CYP1A2ALDH1A1TSHRRAB9ANPC1
Pyrrole SCHEMBL28308888 0.79 RAB9A (0.46) CYP1A2ALDH1A1TSHRRAB9ANPC1
Toluene SCHEMBL10939845 0.78 MAPT (0.48) CYP1A2ALDH1A1TSHRRAB9ANPC1
Acetonitrile SCHEMBL10666479 0.78 ALDH1A1 (0.46) CYP1A2ALDH1A1TSHRRAB9ANPC1
SCHEMBL2520545 0.77 RAB9A (0.47) CYP1A2ALDH1A1TSHRRAB9ANPC1
SCHEMBL1714515 0.77 ALDH1A1 (0.53) CYP1A2ALDH1A1TSHRRAB9ANPC1
1-Methylimidazole SCHEMBL27776909 0.77 ALDH1A1 (0.66) CYP3A4NFKB1QPCTHSD17B10QPCTL
SCHEMBL9680844 0.75 MAOA (0.46) CYP1A2ALDH1A1TSHRRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050208199-A1 Methods and compositions for synthesis of 3'-aminolinkers U CHICAGO ARGONNE LLC 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050208199-A1 Methods and compositions for synthesis of 3'-aminolinkers MECP2, DNMT1, DNMT3L CYP1A2 4428/4885CYP3A4 4086/4885CYP2D6 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.